A part of Watch Media

MedWatchThursday5 October 2023

  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
MedWatchThursday5 October 2023
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Other

MedWatch gets new Norwegian sister media

With a dedicated and professional editorial team, MedWatch.no will track companies and key figures in Norwegian life science.
Anne Grete Storvik, editor of MedWatch.no | Photo: Watch Medier / Fabian Skalleberg Nilsen
Anne Grete Storvik, editor of MedWatch.no | Photo: Watch Medier / Fabian Skalleberg Nilsen
by mikkel aabenhus hemmingsen, translated by daniel pedersen

Media coverage of the Norwegian life science industry will soon be strengthened when Watch Media, overseeing both MedWatch.com and MedWatch.dk, launches MedWatch in Norway in the fall.

With a dedicated and professional editorial team, MedWatch will track companies and key figures from Norwegian life science, covering areas such as biotech and pharma, medtech, diagnostics, and not least digital health.

”The life science industry is experiencing strong growth and is a shining example of how the research and knowledge community plays an increasingly important role in the Norwegian business sector,” says Øyvind Henriksen, head of news of Watch Media’s Norwegian publications.

MedWatch has assembled a strong editorial team, which will be led by 49-year-old Anne Grete Storvik. She joins from FinansWatch.no and brings solid journalistic experience to the table, having reported on the life science industry for ten years at Norwegian media Dagens Medisin.

”Our editorial team is comprised of business reporters and editors who are, or will become, specialists in their respective industries. We believe that strong journalistic coverage, through good and bad times, strengthens all industries,” Henriksen says.

MedWatch.no will be Watch Media’s fifth site in Norway since launching FinansWatch.no in spring 2020. Three weeks ago, the company announced the upcoming launch of EnergiWatch.no. From central Oslo, Watch Media also oversees AdvokatWatch.no and EiendomsWatch.no.

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Foto: Mike Blake
Pharma & biotech

Eli Lilly's head of diabetes and obesity retires

Mike Mason announces that he will retire at the end of the year after 34 years with the company.

For subscribers



Pharma & biotech

DNB expects ALK's tablet sales to recover in 2024

For subscribers



Foto: Stine Bidstrup
Pharma & biotech

Zealand Pharma CEO: "We've never been stronger"

For subscribers


Foto: Tom Little
Pharma & biotech

Investment bank: Novo Nordisk's patent victory is a small win as price negotiations loom

For subscribers


Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

For subscribers


Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

For subscribers


  • Foto: Andrew Kelly/Reuters/Ritzau Scanpix

    Low share price may knock Galecto off the stock exchange

    Nasdaq has requested that the biotech company raise its share price to above USD 1.

    For subscribers


  • Foto: Mike Segar/Reuters/Ritzau Scanpix

    Snack maker keeps an eye on Novo Nordisk's obesity drug

    ”As with anything that could potentially impact our business, we’re looking at it,” says the former Kellogg’s CEO.

  • Foto: Yuriko Nakao/Reuters/Ritzau Scanpix

    Olympus appoints new chief medical officer

    The new medical director is brought in from Medtronic. 

    For subscribers


  • Photo: Staff/Reuters/Ritzau Scanpix

    Novo Nordisk suffers Wegovy defeat to Viatris in patent court

    It is the copy producer Viatris that has challenged three of the patents behind Novo Nordisk’s GLP-1 molecule Semaglutide.

  • Karin Absalonsen, now-former chairperson of Immunitrack and partner at Hannibal Innovation | Photo: Pr

    Eli Lilly makes acquisition in Denmark: Takes over company with 12 employees

    The amount of cash that Eli Lilly had to fork out to gain dominion of Immunitrack has been kept under wraps.

    For subscribers


  • Photo: Novo Nordisk / Pr

    Pharmaceutical industry to grow 4% annually towards 2030

    However, there is one company in the manufacturing sector that is predicted to see negative growth. 

    For subscribers


Further reading

Foto: Mike Blake
Pharma & biotech

Eli Lilly's head of diabetes and obesity retires

Mike Mason announces that he will retire at the end of the year after 34 years with the company.

For subscribers



Novo Nordisk's manufacturing facility in Clayton, the US. | Foto: Novo Nordisk/pr
Pharma & biotech

Novo Nordisk facility in the US allegedly receives FDA notice

The FDA has reportedly notified the company’s management of problematic conditions.

For subscribers



Karin Absalonsen, now-former chairperson of Immunitrack and partner at Hannibal Innovation | Photo: Pr
Pharma & biotech

Eli Lilly makes acquisition in Denmark: Takes over company with 12 employees

The amount of cash that Eli Lilly had to fork out to gain dominion of Immunitrack has been kept under wraps.

For subscribers


Foto: Alexander Heinl/AP/Ritzau Scanpix
Pharma & biotech

Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

Previous studies have shown that alcohol cravings disappeared when people were treated with GLP-1 agonist exanatide.

For subscribers



Photo: Staff/Reuters/Ritzau Scanpix
Pharma & biotech

Novo Nordisk suffers Wegovy defeat to Viatris in patent court

It is the copy producer Viatris that has challenged three of the patents behind Novo Nordisk’s GLP-1 molecule Semaglutide.


Foto: Staff
Pharma & biotech

Novo Nordisk to sell Wegovy in the UK at a fraction of the US price

The price of weight loss drug Wegovy in the UK is completely different price than the in the US.

For subscribers


Jobs

  • Clinical Trial Manager

  • Senior QA Specialists (GMP or GCP)

  • Clinical Supply Manager

  • Senior Legal Councel

  • Global Medical Manager

  • Chemist for Incoming Materials in QC department

  • QA/RA Manager

  • Director, Head of Antibody Technology

  • VP of Software Development, Perfusion Tech

  • Qualified Person to AJ Vaccines

  • Discovery Project Leader, Principal Scientist

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Audit & Supplier Manager

  • Project Director, HR & ESG

  • Scientist - Bioanalysis, Biologics

See all jobs

Latest news

  • Novo Nordisk suffers Wegovy defeat to Viatris in patent court –
  • Pharmaceutical industry to grow 4% annually towards 2030 –
  • Zealand Pharma CEO: "We've never been stronger" –
  • Eli Lilly's head of diabetes and obesity retires –
  • DNB expects ALK's tablet sales to recover in 2024 –
  • Eli Lilly makes acquisition in Denmark: Takes over company with 12 employees –
  • Investment bank: Novo Nordisk's patent victory is a small win as price negotiations loom –
  • Novo Nordisk's semaglutide to be studied for positive effect on alcoholics –
  • Olympus appoints new chief medical officer –
  • Low share price may knock Galecto off the stock exchange –
See all

Jobs

  • Clinical Trial Manager

  • Senior QA Specialists (GMP or GCP)

  • Clinical Supply Manager

  • Senior Legal Councel

  • Global Medical Manager

  • Chemist for Incoming Materials in QC department

  • QA/RA Manager

  • Director, Head of Antibody Technology

  • VP of Software Development, Perfusion Tech

  • Qualified Person to AJ Vaccines

  • Discovery Project Leader, Principal Scientist

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Audit & Supplier Manager

  • Project Director, HR & ESG

  • Scientist - Bioanalysis, Biologics

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

  • About MedWatch

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Banner Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved